KLEORB
tested at a psychologists center (130IQ)..
- Joined
- Oct 15, 2023
- Posts
- 482
- Reputation
- 265
never in my life have ive seen someone get actual good results off minoxidil. its str8 bullshit.
YES HALF OF THIS IS CHAT GPT IM TO CHUD TO GIVE U A FULL STUDY OFF HOMEMADE RESEARCH.WILL I BE TRYING BITMATOPROST? yes.
Eyelashes: Bimatoprost vs No Treatment
https://onlinelibrary.wiley.com/doi/10.1111/j.1346-8138.2012.01579.xhttps://pmc.ncbi.nlm.nih.gov/articles/PMC4499467/ ( bimatoprost can cause iris color changes, which can result in heterochromia (different-colored eyes) if only one eye is exposed to the medication.)
Bimatoprost was originally developed as a glaucoma medication. When applied in or near the eye, it can increase brown pigment (melanin) in the iris over time. This effect:
- Is more likely in people with mixed-color irises (e.g., green-brown, hazel-brown, blue-brown).
- Usually develops gradually over months to years.
- May be permanent, even if the medication is stopped.
- Can lead to noticeable heterochromia if one eye is treated and the other is not.
For people using bimatoprost for eyelash growth (e.g., applied to the upper eyelid margin), the risk appears to be much lower than when the drops are placed directly into the eye, but it is still listed as a potential adverse effect because some medication can reach the ocular surface.
Other eye-area changes can include:
- Darkening of the eyelid skin.
- Increased pigmentation around the eye.
- Longer, thicker eyelashes.
- Rarely, deepening of the upper eyelid sulcus ("sunken-eye" appearance), sometimes called prostaglandin-associated periorbitopathy. (RARE)
- +25% eyelash length
- +106% eyelash thickness/fullness
- +18% darkness
- 78% of users achieved a clinically meaningful improvement by 16 weeks.
Bimatoprost eyelash improvements at 16 weeks
Average changes reported in clinical studies.
Eyebrows: Bimatoprost vs Minoxidil
A randomized study comparing 0.03% bimatoprost with 2% minoxidil for eyebrow hypotrichosis found:
| Outcome at 4 months | Bimatoprost 0.03% | Minoxidil 2% |
|---|---|---|
| Patients with ≥1 grade improvement | 100% | 80% |
| Hair count increase | Higher numerically | Lower numerically |
| Hair diameter increase | Higher numerically | Lower numerically |
| Statistical superiority | No | No |
human data testing?:
| Treatment | Evidence Strength |
|---|---|
| Minoxidil | Strong, FDA-approved, decades of data |
| Bimatoprost | Experimental, limited human data. THIS TREAD WILL BE UPDATED |